JP2024522073A5 - - Google Patents

Info

Publication number
JP2024522073A5
JP2024522073A5 JP2023571762A JP2023571762A JP2024522073A5 JP 2024522073 A5 JP2024522073 A5 JP 2024522073A5 JP 2023571762 A JP2023571762 A JP 2023571762A JP 2023571762 A JP2023571762 A JP 2023571762A JP 2024522073 A5 JP2024522073 A5 JP 2024522073A5
Authority
JP
Japan
Prior art keywords
nanopore
fragment
forming protein
pore
analyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023571762A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024522073A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NL2022/050266 external-priority patent/WO2022245209A2/en
Publication of JP2024522073A publication Critical patent/JP2024522073A/ja
Publication of JP2024522073A5 publication Critical patent/JP2024522073A5/ja
Pending legal-status Critical Current

Links

JP2023571762A 2021-05-18 2022-05-18 ナノポアプロテオミクス Pending JP2024522073A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21174437 2021-05-18
EP21174437.0 2021-05-18
PCT/NL2022/050266 WO2022245209A2 (en) 2021-05-18 2022-05-18 Nanopore proteomics

Publications (2)

Publication Number Publication Date
JP2024522073A JP2024522073A (ja) 2024-06-11
JP2024522073A5 true JP2024522073A5 (https=) 2025-08-07

Family

ID=76011701

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023571762A Pending JP2024522073A (ja) 2021-05-18 2022-05-18 ナノポアプロテオミクス

Country Status (10)

Country Link
US (1) US20240159768A1 (https=)
EP (1) EP4341278A2 (https=)
JP (1) JP2024522073A (https=)
KR (1) KR20240010007A (https=)
CN (1) CN117957243A (https=)
AU (1) AU2022277010A1 (https=)
CA (1) CA3219470A1 (https=)
IL (1) IL308635A (https=)
MX (1) MX2023013655A (https=)
WO (1) WO2022245209A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202112235D0 (en) * 2021-08-26 2021-10-13 Oxford Nanopore Tech Ltd Nanopore
EP4412624A4 (en) 2021-10-04 2025-08-20 Neuvivo Inc TREATMENT METHODS FOR ALS PATIENTS
KR20250116014A (ko) 2022-10-28 2025-07-31 리엑스유니버시테이트 그로닝겐 나노기공-기반 단백질 분석
CN120476132A (zh) * 2022-12-29 2025-08-12 深圳华大生命科学研究院 新型孔蛋白bcp34、其突变体及其应用
GB202305524D0 (en) * 2023-04-14 2023-05-31 Oxford Nanopore Tech Plc Novel pore monomers and pores
CN120917151A (zh) * 2023-04-28 2025-11-07 清华大学 一种被修饰的多肽、多肽复合物、多肽混合物及控制多肽移位速度或表征多肽的系统和方法
WO2025003492A1 (en) * 2023-06-30 2025-01-02 Ecole Polytechnique Federale De Lausanne (Epfl) Uses of aerolysin nanopores
EP4491190A1 (en) * 2023-07-14 2025-01-15 Fundación Imdea Alimentación Small proteins for use as senolytic and senomorphic agents
WO2025138302A1 (zh) * 2023-12-30 2025-07-03 深圳华大生命科学研究院 蛋白测序文库的构建方法及蛋白质的测序方法
WO2025229321A1 (en) * 2024-04-30 2025-11-06 Portal Biotech Ltd. Nanopores and uses thereof for analysis of analytes
WO2026052817A1 (en) * 2024-09-06 2026-03-12 Oxford Nanopore Technologies Plc Method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0820927D0 (en) * 2008-11-14 2008-12-24 Isis Innovation Method
WO2020055246A1 (en) * 2018-09-11 2020-03-19 Rijksuniversiteit Groningen Biological nanopores having tunable pore diameters and uses thereof as analytical tools
CN112500459B (zh) * 2020-02-29 2023-04-07 南京大学 Aerolysin突变纳米孔及其在分子生物检测方面的应用
CN112480204A (zh) * 2020-04-13 2021-03-12 南京大学 一种采用Aerolysin纳米孔道的蛋白质/多肽测序方法

Similar Documents

Publication Publication Date Title
JP2024522073A5 (https=)
Casado et al. Identification of human nasal mucous proteins using proteomics
JP2022518095A5 (https=)
CN105801676B (zh) 一种突变MspA蛋白单体及其表达基因和应用
Hisanaga et al. Molecular architecture of the neurofilament: II. Reassembly process of neurofilament L protein in vitro
BR112021004675A2 (pt) nanoporos biológicos com diâmetros de poros ajustáveis e usos dos mesmos como ferramentas analíticas
JP2005509143A (ja) 診断および治療における可溶性サイトケラチン１断片の使用
Hisanaga et al. Molecular architecture of the neurofilament: I. Subunit arrangement of neurofilament L protein in the intermediate-sized filament
Ji et al. Channel from bacterial virus T7 DNA packaging motor for the differentiation of peptides composed of a mixture of acidic and basic amino acids
JP2025512895A5 (https=)
CN105504065A (zh) 基于霍乱毒素ct结构递药载体蛋白及体外构建方法和应用
CN105541992A (zh) 人MBP18.5kD变体抗原表位肽及特异性检测试剂盒
WO2024138570A1 (zh) 生物纳米孔传感器、其制备方法及应用
Yeo et al. Quantitative profiling of plasma peptides in asthmatic mice using liquid chromatography and mass spectrometry
CN107253987B (zh) 与生殖支原体MgPa相互作用的受体蛋白及其分离方法和用途
TW201237170A (en) Method of examining Riemerella anatipestifer and its kit
CN107188954B (zh) 一种与生殖支原体MgPa特异结合的受体蛋白及其分离方法和用途
CN109777833B (zh) T细胞特异接头蛋白slp-76类泛素化的方法及相应的体外高效鉴定
WO2004065554A3 (en) Human saa3 nucleic acid molecule, protein, and methods of use for same
CN116789852B (zh) 一种检测鳞状上皮细胞癌抗原的荧光探针及用途
RU2848308C2 (ru) Рекомбинантная ДНК psarsN1, рекомбинантная плазмидная ДНК pET-22b-sarsN1, обеспечивающие получение рекомбинантного нуклеокапсидного белка SARSN1 коронавируса, штамм-продуцент E. coli BL21-SARSN1, способный продуцировать рекомбинантный белок SARSN1, иммуногенный в отношении коронавируса SARS-COV-2
Bing et al. Isolation and characterization of two antigenically active peptides from bovine β-lactoglobulin-A
CN107840884A (zh) 一种抗禽类传染性支气管炎病毒的纳米抗体及其制备方法
Ji et al. 31 Channel from Bacterial Virus
JP5048205B2 (ja) 精神分裂病の診断のための新規ペプチド